338 related articles for article (PubMed ID: 36428670)
1. Gallbladder Cancer: Current Multimodality Treatment Concepts and Future Directions.
Sturm N; Schuhbaur JS; Hüttner F; Perkhofer L; Ettrich TJ
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428670
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy for advanced gallbladder cancer (GBC): A systematic review and meta-analysis.
Azizi AA; Lamarca A; McNamara MG; Valle JW
Crit Rev Oncol Hematol; 2021 Jul; 163():103328. PubMed ID: 33862244
[TBL] [Abstract][Full Text] [Related]
3. Molecular Targets and Emerging Therapies for Advanced Gallbladder Cancer.
Canale M; Monti M; Rapposelli IG; Ulivi P; Sullo FG; Bartolini G; Tiberi E; Frassineti GL
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830826
[TBL] [Abstract][Full Text] [Related]
4. Evolving Paradigms in the Systemic Treatment of Advanced Gallbladder Cancer: Updates in Year 2022.
Hu ZI; Lim KH
Cancers (Basel); 2022 Feb; 14(5):. PubMed ID: 35267556
[TBL] [Abstract][Full Text] [Related]
5. Update on immunotherapy in the management of gallbladder cancer.
Kassab J; Saba L; Gebrael G; Kais S; Kassab R; Kourie HR
Immunotherapy; 2023 Jan; 15(1):35-42. PubMed ID: 36617963
[TBL] [Abstract][Full Text] [Related]
6. Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.
Abdel-Rahman O; Elsayed Z; Elhalawani H
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011746. PubMed ID: 29624208
[TBL] [Abstract][Full Text] [Related]
7. Nab-paclitaxel: An effective third-line chemotherapy in patients with advanced, unresectable gallbladder cancer.
Talwar V; Raina S; Goel V; Dash P; Doval DC
Indian J Med Res; 2020 Nov; 152(5):475-481. PubMed ID: 33707389
[TBL] [Abstract][Full Text] [Related]
8. PD-L1 inhibitor plus gemcitabine and cisplatin therapy followed by conversion surgery for initially unresectable advanced gallbladder cancer.
Zhang S; Nie J; Tai S; Zheng T
BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38123314
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Response to Gemcitabine, Cisplatin, and Nab-Paclitaxel Followed by Maintenance Therapy for Advanced Gallbladder Cancer: A Case Report and Literature Review.
Liu T; Li Q; Zhang W; Zhu Q
Front Oncol; 2021; 11():733955. PubMed ID: 34676166
[TBL] [Abstract][Full Text] [Related]
10. Molecular and Immunological Characterization of Biliary Tract Cancers: A Paradigm Shift Towards a Personalized Medicine.
Malenica I; Donadon M; Lleo A
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32781527
[TBL] [Abstract][Full Text] [Related]
11. Gallbladder cancer.
Misra S; Chaturvedi A; Misra NC
Curr Treat Options Gastroenterol; 2006 Apr; 9(2):95-106. PubMed ID: 16539870
[TBL] [Abstract][Full Text] [Related]
12. Locally advanced gallbladder cancer: a review of the criteria and role of imaging.
Gupta P; Meghashyam K; Marodia Y; Gupta V; Basher R; Das CK; Yadav TD; Irrinki S; Nada R; Dutta U
Abdom Radiol (NY); 2021 Mar; 46(3):998-1007. PubMed ID: 32945922
[TBL] [Abstract][Full Text] [Related]
13. Bevacizumab based chemotherapy is a promising option in metastatic gallbladder adenocarcinoma.
Aagre SV; Tonse M; Talele A; Sharma S; Advani SH
Mol Clin Oncol; 2021 Aug; 15(2):153. PubMed ID: 34178324
[TBL] [Abstract][Full Text] [Related]
14. Successful conversion surgery for locally advanced gallbladder cancer after gemcitabine and nab-paclitaxel chemotherapy.
Yang Z; Wu Z; Xiong Y; Liu S; Cai C; Shao Z; Zhu Y; Song X; Shen W; Wang X; Wu X; Gong W
Front Oncol; 2022; 12():977963. PubMed ID: 36052238
[TBL] [Abstract][Full Text] [Related]
15. Gemcitabine-cisplatin (GC) as adjuvant chemotherapy in resected stage II and stage III gallbladder cancers (GBC): a potential way forward.
Ostwal V; Swami R; Patkar S; Majumdar S; Goel M; Mehta S; Engineer R; Mandavkar S; Kumar S; Ramaswamy A
Med Oncol; 2018 Mar; 35(4):57. PubMed ID: 29564657
[TBL] [Abstract][Full Text] [Related]
16. Landmark survival analysis and impact of anatomic site of origin in prospective clinical trials of biliary tract cancer.
McNamara MG; Lopes A; Wasan H; Malka D; Goldstein D; Shannon J; Okusaka T; Knox JJ; Wagner AD; André T; Cunningham D; Moehler M; Jensen LH; Koeberle D; Bekaii-Saab T; Bridgewater J; Valle JW
J Hepatol; 2020 Nov; 73(5):1109-1117. PubMed ID: 32446715
[TBL] [Abstract][Full Text] [Related]
17. [Biliary tract cancer: on the way to a personalized therapy].
Sinn M; Wege H; Stein A
Dtsch Med Wochenschr; 2020 Apr; 145(7):442-446. PubMed ID: 32236923
[TBL] [Abstract][Full Text] [Related]
18. PD-L1 for gallbladder cancer: case report.
Li X; Xian Q; Yan H; Lu L; Wang Q; Zhu D; Wu J
Transl Cancer Res; 2020 May; 9(5):3742-3749. PubMed ID: 35117737
[TBL] [Abstract][Full Text] [Related]
19. Nal-IRI with 5-fluorouracil (5-FU) and leucovorin or gemcitabine plus cisplatin in advanced biliary tract cancer - the NIFE trial (AIO-YMO HEP-0315) an open label, non-comparative, randomized, multicenter phase II study.
Perkhofer L; Berger AW; Beutel AK; Gallmeier E; Angermeier S; Fischer von Weikersthal L; Goetze TO; Muche R; Seufferlein T; Ettrich TJ
BMC Cancer; 2019 Oct; 19(1):990. PubMed ID: 31646981
[TBL] [Abstract][Full Text] [Related]
20. Current management of gallbladder carcinoma.
Zhu AX; Hong TS; Hezel AF; Kooby DA
Oncologist; 2010; 15(2):168-81. PubMed ID: 20147507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
